Latest Operating Expenses News

Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for TR987® despite patient recruitment hurdles, while TR Pro+® sales surge and new distribution deals pave the way for international growth.

Fintech Chain Limited reported a mixed quarter with strong customer receipts and new IoT SaaS product launch, while finalising its ASX delisting. The company’s cash position tightened amid loan repayments and rising operating costs.

Activeport Group Ltd reported a strong Q4 FY25 with significant revenue growth in software and Network as a Service segments, underpinned by new contracts with leading telecom providers and improved cash flow management.

Tombador Iron Limited reported a solid cash position of AUD 9.549 million as it advances the acquisition of the Colomi Iron Project in Brazil, while navigating royalty income challenges and preparing for a capital raise.

Hartshead Resources NL reports steady progress on its P2607 gas development in the UK Southern North Sea, supported by a strong cash position and ongoing joint venture negotiations with RockRose Energy.

InteliCare Holdings reported a $564,000 operating cash outflow in Q4 2025 and has secured $1 million in additional funding to support ongoing operations despite a cash runway under one quarter.

ClearVue Technologies has announced a major leadership overhaul alongside strategic partnerships and market expansion, highlighted by a solar façade trial in Hong Kong demonstrating a payback period as low as 2.6 years.

MedAdvisor Solutions reported a 16.6% revenue decline in 4Q FY25, driven by US market challenges, while completing the sale of its ANZ business and initiating a strategic review of its US operations.

MedAdvisor reports a significant revenue decline in FY25 amid US program delays but strengthens its balance sheet through a capital raise and ANZ business sale. The company signals a strategic pivot with potential US business divestment on the horizon.

Stakk Limited has reported a remarkable 262% year-on-year increase in annual recurring revenue receipts, driven by its Embedded Finance services in the US and Australia. The company is poised to broaden its offerings with new client wins and the upcoming launch of Embedded Lending capabilities.

Dotz Nano has partnered with CarbonCapture Inc. to scale its high-performance direct air capture sorbent, while raising AU$1.2 million to fund its DotzEarth project amid ongoing funding timing challenges.

Neurotech International reports encouraging Phase I human pharmacokinetic results for its pediatric cannabinoid drug NTI164, alongside published clinical trial data in Rett Syndrome and key regulatory progress in the US and Australia.